Notably, in patients with obesity, adiponectin can regulate the activity of pro-inflammatory CD4+ T cells (108), and its effectiveness in treating obesity has been demonstrated (109). This evidence concerns the gene CD4 and obesity due to melanocortin 4 receptor deficiency.